SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000912282-18-000051
Filing Date
2018-03-05
Accepted
2018-03-05 16:31:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 aphria-scythian13g_030518.htm SC 13G 51595
  Complete submission text file 0000912282-18-000051.txt   53171
Mailing Address 365 BAY STREET SUIT 400 TORONTO A6 M5H2V1
Business Address 365 BAY STREET SUIT 400 TORONTO A6 M5H2V1 416-366-9192
Scythian Biosciences Corp. (Subject) CIK: 0001710138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90407 | Film No.: 18666481
SIC: 2834 Pharmaceutical Preparations

Mailing Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8
Business Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8 (844) 427-4742
Aphria Inc. (Filed by) CIK: 0001733418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 0531
Type: SC 13G